Shao XY - Search Results

1

[Application of the Second Revision of the International Staging System (R2-ISS) in the prognostic assessment of newly diagnosed multiple myeloma].

Yan J, Zhou DM, Shao XY, Xu Y, Chen B. Yan J, et al. Among authors: shao xy. Zhonghua Xue Ye Xue Za Zhi. 2024 Feb 14;45(2):170-177. doi: 10.3760/cma.j.cn121090-20230810-00058. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 38604794 Free PMC article. Chinese.

2

[Analysis of the effects of low/intermediate dose of coagulation factor Ⅷ on 30 adult patients with severe hemophilia A in a single center].

Yuan YH, Xu PP, Xu YY, Liu S, Shao XY, Zhang WJ, Gong L, Zhou M, Chen B, Zhou RF. Yuan YH, et al. Among authors: shao xy. Zhonghua Xue Ye Xue Za Zhi. 2023 Jan 14;44(1):38-42. doi: 10.3760/cma.j.issn.0253-2727.2023.01.007. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 36987721 Free PMC article. Chinese.

3

[Inflammatory rhabdomyoblastic tumor: a clinicopathological analysis of 3 cases].

Gong CX, Shao X, Fan QH. Gong CX, et al. Zhonghua Bing Li Xue Za Zhi. 2023 Feb 8;52(2):169-171. doi: 10.3760/cma.j.cn112151-20220507-00380. Zhonghua Bing Li Xue Za Zhi. 2023. PMID: 36748140 Chinese.

4

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages.

Xu D, Chen WQ, Liang MX, Chen X, Liu Z, Fei YJ, Shao XY, Wu Y, Zhang W, Tang JH. Xu D, et al. Among authors: shao xy. Cancer Cell Int. 2023 Jul 14;23(1):137. doi: 10.1186/s12935-023-02980-0. Cancer Cell Int. 2023. PMID: 37452413 Free PMC article.

5

Case Report: A rare synchronous multiple gastric carcinoma achieved progression-free disease through NGS-guided serial treatment.

Shao X, Yin J, Wang D, Huang E, Zhang Y, Yin JC, Huang C, Wu H, Wu X. Shao X, et al. Front Oncol. 2023 Jul 11;13:1195837. doi: 10.3389/fonc.2023.1195837. eCollection 2023. Front Oncol. 2023. PMID: 37496667 Free PMC article.

6

TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2⁺ breast cancer.

Shao X, Yang D, Shan L, Yan X, Xu D, Li L, Sun Y, Yu Q, Zhou H, Ding Y, Tang J. Shao X, et al. Arch Toxicol. 2024 Mar;98(3):865-881. doi: 10.1007/s00204-023-03670-6. Epub 2024 Jan 11. Arch Toxicol. 2024. PMID: 38212449

7

CT-based body composition parameters predict the loss of response to infliximab in patients with Crohn's disease.

Li S, Wu H, Miao S, Huang C, Zhang Y, Shao X, Chen C, Wu X. Li S, et al. Am J Med Sci. 2024 Sep 3:S0002-9629(24)01441-1. doi: 10.1016/j.amjms.2024.08.025. Online ahead of print. Am J Med Sci. 2024. PMID: 39237035

8

[HBVcccDNA of patients with hepatitis B in the serum, PBMC and liver tissue distribution].

Zhang YL, Xu D, Wu XX, Wu J, Shao XY, Chen H, Zhang Q. Zhang YL, et al. Among authors: shao xy. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Oct;22(5):342-4. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008. PMID: 19469169 Chinese.

9

Successful guselkumab treatment of a refractory psoriasis patient with Graves' disease: a case report.

Shao X, Huang K, Chen A, Liu C, Xiong J, Pan Y, Chen X, Wang P. Shao X, et al. J Int Med Res. 2024 Apr;52(4):3000605241239856. doi: 10.1177/03000605241239856. J Int Med Res. 2024. PMID: 38656269 Free PMC article.

10

The correlation of sarcopenia and adverse events of imatinib therapy postoperatively in gastrointestinal stromal tumor through computed tomography quantitative body composition.

Shao X, Wu H, Huang C, Yin H, Wang P, Wu X. Shao X, et al. J Gastrointest Surg. 2024 Apr;28(4):375-380. doi: 10.1016/j.gassur.2024.01.025. Epub 2024 Feb 1. J Gastrointest Surg. 2024. PMID: 38583886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters